Will patient-centric sampling become the norm for clinical trials after COVID-19?
Christopher James, Matthew Barfield, Katie F. Maass, Shefali Patel, Melanie Anderson
Topics & Concepts
Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Clinical trialNorm (philosophy)MedicineIntensive care medicineVirologyInternal medicinePolitical scienceOutbreakInfectious disease (medical specialty)DiseaseLawBiosimilars and Bioanalytical MethodsHealth Systems, Economic Evaluations, Quality of LifeStatistical Methods in Clinical Trials